BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6369001)

  • 21. Hyperprolactinemia and its effect on female sterility.
    Atasü T; Kösebay D; Arvas M
    Biol Res Pregnancy Perinatol; 1985; 6(3):133-6. PubMed ID: 3834948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperprolactinemia and pregnancy].
    Ionescu O; Vulpoi C; Cristea C; Ionescu D; Zbranca E
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):60-4. PubMed ID: 12635361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
    Baranowska B; Jeske W; Szymanowski J; Piechna K
    J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin and antipsychotic medications: mechanism of action.
    Petty RG
    Schizophr Res; 1999 Mar; 35 Suppl():S67-73. PubMed ID: 10190227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminergic regulation of neuroendocrinological functions: theoretical background and some clinical examples.
    Männistö PT
    Med Biol; 1987; 65(2-3):121-6. PubMed ID: 2888929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep.
    Clarenbach P; Del Pozo E; Brownell J; Heredia E; Spiegel R; Cramer H
    Brain Res; 1980 Dec; 202(2):357-63. PubMed ID: 7437907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine as a prolactin (PRL) inhibitor.
    Ben-Jonathan N; Hnasko R
    Endocr Rev; 2001 Dec; 22(6):724-63. PubMed ID: 11739329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern drug treatment of hyperprolactinemia].
    Rachev E; Spasov S
    Akush Ginekol (Sofiia); 1985; 24(6):81-4. PubMed ID: 3911788
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical therapy of hyperprolactinemia.
    Dalkin AC; Marshall JC
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):259-76. PubMed ID: 2663475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ergot alkaloids on the hypothalamic-pituitary axis.
    Flückiger E; Doepfner W; Markó M; Niederer W
    Postgrad Med J; 1976; 52suppl 1():57-63. PubMed ID: 959126
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroendocrine effects of neuropsychotropic drugs and their possible influence on toxic reactions in animals and man -- the role of the dopamine-prolactin system.
    Horowski R; Gräf KJ
    Arch Toxicol Suppl; 1979; (2):93-104. PubMed ID: 288372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Human prolactin (author's transl)].
    von Werder K; Rjosk HK
    Klin Wochenschr; 1979 Jan; 57(1):1-12. PubMed ID: 366279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin resistance to bromocryptine treatment: a case report.
    Borenstein R; Kessler I; Ben-David M
    Int J Fertil; 1981; 26(4):287-9. PubMed ID: 6120911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
    Del Pozo E; Del Re RB; Varga L; Friesen H
    J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells.
    Maurer RA
    J Biol Chem; 1980 Sep; 255(17):8092-7. PubMed ID: 6893323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolactin, bromocriptine and dopaminergic neurotransmission.
    Lamberts SW; Birkenhäger JC
    Neth J Med; 1976; 19(3):113-7. PubMed ID: 6921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.